It has been widely demonstrated that the overexpression of CTLA-4 is associated with reduced interleukin-2 (IL-2) expression and T-cell cycle arrest, resulting in the reduction of T-cell function and immune evasion of cancer cells (23). Here, IL2 is linked to cancer.